SynapDx Obtains $2,000,000 New Financing Round

  • Feed Type
  • Date
    2/22/2013
  • Company Name
    SynapDx
  • Mailing Address
    153 Cordaville Road Southborough, MA 01772
  • Company Description
    SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism.
  • Website
    http://www.synapdx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This investment will support the clinical development of SynapDx’s breakthrough blood-based autism spectrum disorder (ASD) diagnostic test, designed to help clinicians identify children with autism earlier than they do today.
  • M&A Terms
  • Venture Investor
    Laboratory Corporation of America